Co-culturing OT1 T cells with MC38 cells that were pretreated or not with the Hsp90 inhibitor NVP-AUY922 thus provides an opportunity to directly measure the impact of Hsp90 inhibition on activation of tumour-specific T cells. The gene discussed is HSP90AB1; the disease is neoplasm.